Glioblastoma
2 competing products in clinical development for Glioblastoma.
Pipeline by Phase
Phase 11
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Nimotuzumab + Temozolomide | Sun Pharmaceutical | Phase 2 | Completed | 35 |
| ASP8374 + cemiplimab | Astellas Pharma | Phase 1 | Completed | 29 |